Tanke Biosciences Corp Balance Sheet
TNBI|3 years of annual SEC 10-K data (FY2010-FY2012)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
Tanke Biosciences Corp had $29M in total assets and $16M in shareholders' equity as of FY2012. Total debt was $2M against $6M in cash, resulting in a $4M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2012 | FY2011 | FY2010 |
|---|---|---|---|
| Cash & Equivalents | $6.2M | $7.7M | $2.2M |
| Accounts Receivable | $2.0M | $1.9M | - |
| Inventory | $1.4M | $1.2M | - |
| Current Assets | $22.4M | $18.9M | - |
| PP&E (Net) | $4.8M | $4.8M | - |
| Total Assets | $28.8M | $24.9M | - |
| Current Liabilities | $12.1M | $3.5M | - |
| Total Debt | $2.1M | $1.4M | - |
| Shareholders' Equity | $15.8M | $15.9M | $10.3M |